Comment
doi: 10.1016/S1470-2045(17)30854-9.
Epub 2017 Nov 17.
Complexity of intermittent letrozole adjuvant therapy
Affiliations
- PMID: 29158010
- DOI: 10.1016/S1470-2045(17)30854-9
Item in Clipboard
Comment
Complexity of intermittent letrozole adjuvant therapy
Lancet Oncol.
2018 Jan.
No abstract available
Comment on
-
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.Lancet Oncol. 2018 Jan;19(1):127-138. doi: 10.1016/S1470-2045(17)30715-5. Epub 2017 Nov 17. Lancet Oncol. 2018. PMID: 29158011 Clinical Trial.
Similar articles
-
Letrozole: a pharmacoeconomic review of its use in postmenopausal women with breast cancer.Pharmacoeconomics. 2006;24(5):495-517. doi: 10.2165/00019053-200624050-00007. Pharmacoeconomics. 2006. PMID: 16706574 Review.
-
Letrozole as adjuvant therapy for postmenopausal women with early breast cancer.Manag Care Interface. 2007 Sep;20(9):30-1, 36. Manag Care Interface. 2007. PMID: 18161388 No abstract available.
-
Intermittent Letrozole Administration as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive Early Breast Cancer: A Biologic Study.Clin Breast Cancer. 2015 Oct;15(5):e257-62. doi: 10.1016/j.clbc.2015.03.007. Epub 2015 Apr 30. Clin Breast Cancer. 2015. PMID: 26362840
-
Cost effectiveness of extended adjuvant letrozole in postmenopausal women after adjuvant tamoxifen therapy: the UK perspective.Pharmacoeconomics. 2006;24(3):237-50. doi: 10.2165/00019053-200624030-00004. Pharmacoeconomics. 2006. PMID: 16519546 Clinical Trial.
-
The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer.Expert Rev Anticancer Ther. 2007 May;7(5):627-34. doi: 10.1586/14737140.7.5.627. Expert Rev Anticancer Ther. 2007. PMID: 17492927 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
